1
Clinical Trials associated with six-Valent Group B streptococcus Glycoconjugate vaccine( Suzhou Ju Microbial) / Not yet recruitingPhase 1 评价6价B族链球菌结合疫苗接种18-49周岁健康人群后安全性与初步免疫原性的随机、盲法、安慰剂对照Ⅰ期临床试验
[Translation] A randomized, blinded, placebo-controlled phase I clinical trial evaluating the safety and preliminary immunogenicity of hexavalent group B streptococcal conjugate vaccine in healthy individuals aged 18-49 years.
主要目的:
评价6价B族链球菌结合疫苗在18至49周岁健康人群中接种的安全性。
探索性目的:
初步观察6价B族链球菌结合疫苗在18至49周岁健康人群接种的免疫原性。
[Translation] Primary objective: To evaluate the safety of the hexavalent group B streptococcal conjugate vaccine in healthy individuals aged 18 to 49 years.
Exploratory objective: To preliminarily observe the immunogenicity of the hexavalent group B streptococcal conjugate vaccine in healthy individuals aged 18 to 49 years.
100 Clinical Results associated with six-Valent Group B streptococcus Glycoconjugate vaccine( Suzhou Ju Microbial)
100 Translational Medicine associated with six-Valent Group B streptococcus Glycoconjugate vaccine( Suzhou Ju Microbial)
100 Patents (Medical) associated with six-Valent Group B streptococcus Glycoconjugate vaccine( Suzhou Ju Microbial)
100 Deals associated with six-Valent Group B streptococcus Glycoconjugate vaccine( Suzhou Ju Microbial)